Lotus Health Group Stock Fundamentals

600186 Stock   5.25  0.20  3.96%   
Lotus Health Group fundamentals help investors to digest information that contributes to Lotus Health's financial success or failures. It also enables traders to predict the movement of Lotus Stock. The fundamental analysis module provides a way to measure Lotus Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lotus Health stock.
At present, Lotus Health's Selling General Administrative is projected to decrease significantly based on the last few years of reporting. The current year's Operating Income is expected to grow to about 193.8 M, whereas Interest Expense is forecasted to decline to about 534.9 K.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Lotus Health Group Company Current Valuation Analysis

Lotus Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Lotus Health Current Valuation

    
  8.59 B  
Most of Lotus Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lotus Health Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Lotus Health Group has a Current Valuation of 8.59 B. This is 55.74% lower than that of the Food Products sector and significantly higher than that of the Consumer Staples industry. The current valuation for all China stocks is 48.33% higher than that of the company.

Lotus Health Group Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Lotus Health's current stock value. Our valuation model uses many indicators to compare Lotus Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lotus Health competition to find correlations between indicators driving Lotus Health's intrinsic value. More Info.
Lotus Health Group is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.39  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Lotus Health Group is roughly  2.59 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Lotus Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Lotus Health's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Lotus Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lotus Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Lotus Health could also be used in its relative valuation, which is a method of valuing Lotus Health by comparing valuation metrics of similar companies.
Lotus Health is currently under evaluation in current valuation category among its peers.

Lotus Fundamentals

About Lotus Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Lotus Health Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lotus Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lotus Health Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue2.1 BB
Cost Of Revenue1.7 B1.7 B

Currently Active Assets on Macroaxis

Other Information on Investing in Lotus Stock

Lotus Health financial ratios help investors to determine whether Lotus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lotus with respect to the benefits of owning Lotus Health security.